139 related articles for article (PubMed ID: 37552310)
1. Financial conflicts of interest of physicians followed by oncology journals on Twitter.
Betts C; Kakkilaya A; Vasireddy S; Arora N; Prasad V; Powell K
J Cancer Res Clin Oncol; 2023 Nov; 149(15):14137-14144. PubMed ID: 37552310
[TBL] [Abstract][Full Text] [Related]
2. Financial conflicts of interest of physicians followed by neurosurgical journals on Twitter.
Powell K; McCall K; Hooda K; Prasad V; Kakkilaya A
Int J Health Plann Manage; 2023 May; 38(3):679-686. PubMed ID: 36597174
[TBL] [Abstract][Full Text] [Related]
3. Financial conflicts of interest of OncoAlert: An informal oncology professional network.
Powell K; Kakkilaya A; Haslam A; Prasad V
J Cancer Policy; 2022 Dec; 34():100369. PubMed ID: 36396090
[TBL] [Abstract][Full Text] [Related]
4. Financial Relationships With Industry of Editorial Board Members of the Three Journals of the American Society for Radiation Oncology.
Verma V
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):286-291. PubMed ID: 28871971
[TBL] [Abstract][Full Text] [Related]
5. Do Editorialists With Industry-Related Conflicts of Interest Write Unduly Favorable Editorials for Cancer Drugs in Top Journals?
Sharma S; Booth CM; Eisenhauer EA; Gyawali B
J Natl Compr Canc Netw; 2021 Jul; 19(11):1258-1263. PubMed ID: 34325401
[TBL] [Abstract][Full Text] [Related]
6. Industry payments to US physicians for cancer therapeutics: An analysis of the 2016-2018 open payments datasets.
Meyers DE; Chisamore TM; McInnes MDF; Gyawali B; Prasad V; Booth CM
J Cancer Policy; 2021 Jun; 28():100283. PubMed ID: 35559912
[TBL] [Abstract][Full Text] [Related]
7. Industry compensation and self-reported financial conflicts of interest among authors of highly cited peripheral artery disease studies.
Bellomo TR; Hwang C; Spector-Bagdady K; Stanley JC; Corriere MA
J Vasc Surg; 2020 Aug; 72(2):673-684. PubMed ID: 31980241
[TBL] [Abstract][Full Text] [Related]
8. Undisclosed financial conflicts of interest among authors of American Society of Clinical Oncology clinical practice guidelines.
Saleh RR; Majeed H; Tibau A; Booth CM; Amir E
Cancer; 2019 Nov; 125(22):4069-4075. PubMed ID: 31355923
[TBL] [Abstract][Full Text] [Related]
9. Financial Conflicts of Interest Change After a High-Impact Clinical Trial Publication in Oncology.
Cambridge CL; Gatof ES; Weiss GJ; Davis RB
J Patient Cent Res Rev; 2020; 7(3):249-254. PubMed ID: 32760756
[TBL] [Abstract][Full Text] [Related]
10. Financial Conflicts of Interest Among Emergency Medicine Journals' Editorial Boards.
Niforatos JD; Narang J; Trueger NS
Ann Emerg Med; 2020 Mar; 75(3):418-422. PubMed ID: 30955988
[TBL] [Abstract][Full Text] [Related]
11. The relation between publication rate and financial conflict of interest among physician authors of high-impact oncology publications: an observational study.
Kaestner V; Edmiston JB; Prasad V
CMAJ Open; 2018 Jan; 6(1):E57-E62. PubMed ID: 29382668
[TBL] [Abstract][Full Text] [Related]
12. Financial Conflicts of Interest Among Authors of Clinical Practice Guidelines for Routine Screening Mammography.
Combs T; Tritz D; Ivy H; von Borstel D; Horn J; Vassar M
J Am Coll Radiol; 2019 Nov; 16(11):1598-1603. PubMed ID: 31152689
[TBL] [Abstract][Full Text] [Related]
13. Nonresearch Pharmaceutical Industry Payments to Oncology Physician Editors.
Haque W; Alvarenga M; Hsiehchen D
Oncologist; 2020 Jun; 25(6):e986-e989. PubMed ID: 32272494
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Financial Conflicts of Interest and Quality of Evidence Underlying the American Diabetes Association Clinical Practice Guidelines: The Standards of Medical Care in Diabetes, 2021.
Shigeta H; Murayama A; Kamamoto S; Saito H; Ozaki A
Cureus; 2023 Mar; 15(3):e36567. PubMed ID: 37095789
[TBL] [Abstract][Full Text] [Related]
15. Industry payments to physician journal editors.
Wong VSS; Avalos LN; Callaham ML
PLoS One; 2019; 14(2):e0211495. PubMed ID: 30730904
[TBL] [Abstract][Full Text] [Related]
16. Financial relationships between industry and principal investigators of US cooperative group randomized cancer clinical trials.
Metzger AL; Kusi Appiah A; Wright CM; Jairam V; Amini A; Park HS; Welsh JW; Thomas CR; Verma V; Ludmir EB
Int J Cancer; 2021 Nov; 149(9):1683-1690. PubMed ID: 34173669
[TBL] [Abstract][Full Text] [Related]
17. Financial Relationships With Industry Among National Comprehensive Cancer Network Guideline Authors.
Mitchell AP; Basch EM; Dusetzina SB
JAMA Oncol; 2016 Dec; 2(12):1628-1631. PubMed ID: 27561170
[TBL] [Abstract][Full Text] [Related]
18. Payments by US pharmaceutical and medical device manufacturers to US medical journal editors: retrospective observational study.
Liu JJ; Bell CM; Matelski JJ; Detsky AS; Cram P
BMJ; 2017 Oct; 359():j4619. PubMed ID: 29074628
[No Abstract] [Full Text] [Related]
19. Quality of content reporting on two major oncology media websites: OncLive and Targeted Oncology.
Sharma N; Wayant C; Neupane K; Lenka J; Berger K; Goodman AM; Booth CM; Prasad V; Mohyuddin GR
J Cancer Policy; 2023 Jun; 36():100411. PubMed ID: 36773798
[TBL] [Abstract][Full Text] [Related]
20. Health Care Industry Payments to Editorial Board Members of Major Neurosurgery Journals Between 2017 and 2022.
Harlianto NI; Harlianto ZN
Neurosurgery; 2024 Apr; ():. PubMed ID: 38587376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
